No bad news YET. No safety issues, no allegations of lack of effectiveness, NOTHING. Arena Pharmaceuticals has been adrift for the last few weeks in the $6.50 to $7.00 range. The shares hit a high of $8.00 a month ago, a high which was short lived. Nonetheless there is a huge upside potential. The beauty of this potential is that it will be realized by September 16th.
Please check out these blog entries to gain some more perspective.
What with the market in a funk and pessimism pervasive, a buying opportunity has presented itself. Check it out. The fat market is huge and its screaming out for a drug. Be in or be out, the choice is clear. So it goes.